Filing Flows › Accendra Health (ACH) › Home respiratory therapy revenue
Accendra Health (ACH) Home respiratory therapy revenue by quarter
Accendra Health's Home respiratory therapy revenue was $88.9M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 3 quarters it ranged from $88.9M (Q3 2026) to $97.2M (Q1 2026).
| Quarter | Home respiratory therapy revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $88.9M | -2% | — |
| Q2 2026 | $91.0M | -6% | — |
| Q1 2026 | $97.2M | — | — |
Q3 2026 at a glance
Accendra Health, Q3 2026: revenue $602M (-14% year over year), operating margin 0.2%, net loss $19.7M, operating cash flow −$17.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Accendra Health's Home respiratory therapy revenue?
Accendra Health's Home respiratory therapy revenue was $88.9M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Accendra Health's Home respiratory therapy revenue changed?
Over the last 3 quarters it ranged from $88.9M (Q3 2026) to $97.2M (Q1 2026).